about
A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patientsA type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteriaHow bioinformatics influences health informatics: usage of biomolecular sequences, expression profiles and automated microscopic image analyses for clinical needs and public healthAdvances toward the elucidation of hypertonic saline effects on Pseudomonas aeruginosa from cystic fibrosis patientsCulture enriched molecular profiling of the cystic fibrosis airway microbiomeModelling co-infection of the cystic fibrosis lung by Pseudomonas aeruginosa and Burkholderia cenocepacia reveals influences on biofilm formation and host responseDetermining cystic fibrosis-affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling.Monocytes from cystic fibrosis patients are locked in an LPS tolerance state: down-regulation of TREM-1 as putative underlying mechanism.Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections.Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients.Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapyAnalysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centers.Development of real-time PCR assays for detection of the Streptococcus milleri group from cystic fibrosis clinical specimens by targeting the cpn60 and 16S rRNA genesReliability of quantitative real-time PCR for bacterial detection in cystic fibrosis airway specimensPulmonary exacerbations in cystic fibrosis with negative bacterial cultures.Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosisRevealing the dynamics of polymicrobial infections: implications for antibiotic therapy.Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbationsAdaptation of Pseudomonas aeruginosa in Cystic Fibrosis airways influences virulence of Staphylococcus aureus in vitro and murine models of co-infectionMicrobiome in cystic fibrosis: Shaping polymicrobial interactions for advances in antibiotic therapy.Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methodsPrevalence and impact of Streptococcus pneumoniae in adult cystic fibrosis patients: a retrospective chart review and capsular serotyping study.Polymicrobial interactions: impact on pathogenesis and human disease.Homeostasis and its disruption in the lung microbiome.A quantitative analysis of Ureaplasma urealyticum and Ureaplasma parvum compared with host immune response in preterm neonates at risk of developing bronchopulmonary dysplasiaIntegrated approach to understanding the onset and pathogenesis of black band disease in corals.The cystic fibrosis microbiome in an ecological perspective and its impact in antibiotic therapy.Molecular Identification of Staphylococcus aureus in Airway Samples from Children with Cystic Fibrosis.Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections.Insights into the respiratory tract microbiota of patients with cystic fibrosis during early Pseudomonas aeruginosa colonization.Prevalence of streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability.Cystic fibrosis lung environment and Pseudomonas aeruginosa infection.Modulation of behaviour and virulence of a high alginate expressing Pseudomonas aeruginosa strain from cystic fibrosis by oral commensal bacterium Streptococcus anginosus.Metagenomic study of the oral microbiota by Illumina high-throughput sequencing.Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection.Lung transplantation: infection, inflammation, and the microbiome.The polymicrobial nature of airway infections in cystic fibrosis: Cangene Gold Medal Lecture.Development of broad-spectrum antibiofilm drugs: strategies and challenges.Azithromycin paradox in the treatment of cystic fibrosis airway disease.
P2860
Q24652357-EFD30474-37EF-4667-B5C3-7073C8FFCFA5Q28492922-1051AF21-831D-414F-898D-8D516B239005Q28649612-4C223F23-25A2-45EE-8D58-5051EF1F5D11Q28658389-3E0AC814-5002-4687-A2E3-E0550D257211Q28742049-4E97BCF7-1BB1-41C5-A4D6-735DB707C0D6Q30394473-96750785-4C85-4A05-88C1-423E69C17A61Q30882278-AFE03FCB-6DCA-42D1-9CEE-175D57CD543AQ33352036-28CCA982-8356-4A4B-B614-21D05F8934C4Q33379091-BB4AA1EE-B537-4292-872D-360D99155EC4Q33550582-227BF76E-4CF9-4679-9F03-DDA6A11C1BB1Q33697276-94AD7056-A239-4BB9-8B8C-4C46D1516BD1Q33743766-4F736960-431F-4143-A888-9838F6DE622BQ33769617-774D185D-AF99-4A5B-8942-1DA655A0B35DQ33770039-68E28CFF-DD87-47A0-A7CB-535CCCE3D3ACQ34118967-F7C74C7D-20A7-4B8A-835C-38C353A23E7BQ34297656-7681244B-82CF-41D6-B859-01E2813574BFQ34536205-BF75E66A-5BCC-4964-94B5-0AF600B02CCEQ34554419-A8D7928C-A209-4E27-93AF-641C92F4BB70Q34706914-57F1AFCB-ECBC-443B-AE58-6539B57AD87FQ35113179-A21A1ECD-7863-454C-BD5C-FAB64404A01AQ35124580-66C90A12-56FF-4456-A6F0-56C00AFE8BE2Q35127881-799055EA-54CD-4FD8-9172-818EDB45C721Q35616635-FE703254-2E1B-4871-AFBC-4BEA04363B1CQ35666253-C65764B1-6CCF-4558-8C9A-76E23FB32A04Q35798039-3D9D5D08-B6E3-4DE7-AB49-1FF3AA3A6D1EQ35807027-8D84176C-B422-4879-93DB-7EE2B8579688Q35835658-F1529D9B-A747-4CCD-A122-610FDF67C48EQ35861377-C10B52B0-4E14-495A-9FC9-45F9E978B731Q35903821-1B29B07D-6E1D-4496-B5BC-0118703E221FQ35918209-965504FD-8173-43EB-B74F-2E9E87DD95AFQ35930737-07AADCFD-6652-4FCE-AFCB-D4F0B4FAB442Q36152854-8089494E-3731-4001-8A2F-A76D546AC64CQ36213685-6B530C12-044E-44A3-9253-F5FDDD626502Q36310773-94691101-5952-4298-93B6-FC47BA344B59Q36599530-C0ADB76A-0AE7-471C-BC1C-001987248D15Q36895659-A52936A9-7E74-4A2C-90AE-D9CDBBDEFD3DQ37832677-E4CD8765-DD86-4C01-AA81-43E1E2AC3765Q37843465-5004F484-B24B-442A-8129-FDAE6F42DAEFQ38522806-9C3881CF-2DFC-4E94-9F65-62FB4283E0FBQ39835134-E3A2FED3-ADB9-4957-9123-832DB9141034
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Cystic fibrosis: a polymicrobial infectious disease.
@en
type
label
Cystic fibrosis: a polymicrobial infectious disease.
@en
prefLabel
Cystic fibrosis: a polymicrobial infectious disease.
@en
P2093
P2860
P356
P1433
P1476
Cystic fibrosis: a polymicrobial infectious disease.
@en
P2093
Christopher D Sibley
Harvey Rabin
Michael G Surette
P2860
P356
10.2217/17460913.1.1.53
P577
2006-06-01T00:00:00Z